Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- AMPK AMP-activated protein kinase (1)
- Why have a signalling pathway activated by AMP?
- AMPK promoting catabolism, inhibiting anabolism
- AMPK effects on mitochondrial function
- Function of AMPK orthologues in lower eukaryotes
- AMPK AMP-activated protein kinase (2)
- Canonical activation by adenine nucleotides
- Crystal structure of AMPK
- AMPK AMP-activated protein kinase (3)
- Non-canonical activation by Ca2+ and CAMKK2
- Nutrient sensing - activation by glucose starvation
- Effect of glucose removal on AMPK and AMP
- Glucose sensing: mTORC1 and AMPK systems
- Non-canonical activation by fatty acyl-CoA esters
- Sensing of glucose and fatty acids by AMPK
- AMPK AMP-activated protein kinase (4)
- A target for type 2 diabetes
- Development of the anti-diabetic drug metformin
- Drugs activate MAPK by at least three mechanisms
- AMPK AMP-activated protein kinase (5)
- Is AMP (like LKB1) a tumour suppressor?
- Effect of AMPK knockout on T-cell lymphoma
- Do biguanides protect against T-cell lymphoma?
- AMPK inhibitors may be useful for treating cancer
- AMP-activated protein kinase - conclusions
- Acknowledgements
Topics Covered
- AMPK as an energy sensor
- Canonical activation of AMPK
- Structure of AMPK
- Non-canonical activation of AMPK
- A drug target in type 2 diabetes
- A drug target in cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Hardie, G. (2021, November 28). Roles of AMPK in energy homeostasis and nutrient sensing [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/YHYK9821.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Grahame Hardie has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Oncology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Grahame Hardie from the School of Life Sciences
at the University of Dundee, in Scotland.
I'm going to be talking to you today about the AMP-activated protein kinase,
and its rôles in energy homeostasis and in nutrient sensing.
0:16
Throughout the talk, I'm going to be using the acronym AMPK
to signify AMP-activated protein kinase.
I'll divide the talk into five sections.
Firstly, I'll introduce you to the AMPK system, and explain the concept
that it acts as a sensor of cellular energy status.
Next, I'll talk about its classical, or canonical, activation by changes
in adenine nucleotide ratios, and I'll also discuss its structure.
Next, I'll discuss various non-canonical activation mechanisms
that have been discovered more recently, including the manner in which it
can sense availability of glucose and fatty acids.
Next, I'll discuss why it's a target for drugs used to treat type 2 diabetes,
and I'll summarise what progress has been made in that direction.
Finally, I'll talk about a topic in which there is much current interest,
which is the potential rôle of AMPK as a target for drugs used to treat cancer.
Let's start by introducing the AMPK system.
1:13
I like to keep things as simple as possible, so this is my view of the eukaryotic cell,
which is an oval with AMPK at the centre.
There are, of course, one or two other things in the cell, and two of these are ATP and ADP.
I like to draw the analogy between ATP and ADP,
and the chemicals in a rechargeable electrical battery.
Using this analogy, catabolism charges up the battery by converting ADP to ATP.
Practically everything else that the cell does
- whether it's growing, dividing, moving, or secreting things into the medium -
requires energy, and tends to flatten the battery by converting ATP back to ADP.
It's obviously very important that these two processes are kept in balance,
and the fact that ATP and ADP levels are usually pretty constant
indicates that there are systems within the cell that regulate this balance.
Although there are others, I would argue that AMPK is the most important of these.
In a normal healthy cell that has plenty of glucose and oxygen,
and when the environmental conditions are ideal,
catabolism maintains the ATP to ADP ratio at around 10:1.
Under these conditions, ATP is in the low millimolar range, and it binds to AMPK
and keeps it in its largely inactive state.
Now imagine that the cell experiences some kind of stress.
It could be a stress that interferes with the production of ATP by catabolism,
such as interruption of the blood supply, also known as ischaemia.
Alternatively, it could be a stress that accelerates ATP consumption,
such as contraction in a muscle cell.
Either way, there'd be a tendency for the ADP to ATP ratio to increase,
which I've indicated here by changing the font size.
Any increase in ADP to ATP is immediately amplified by the enzyme adenylate kinase,
into an even larger rise in the AMP to ADP ratio.
In fact, if the adenylate kinase reaction is at equilibrium
(which appears to be the case in most cells), it's easy to show that the AMP to ADP ratio
will vary as the square of the ADP to ATP ratio.
Thus, if the ADP to ATP ratio rises by three-fold, the AMP to ATP ratio will rise nine-fold,
making the latter a much more sensitive indicator of cellular energy status.
It's therefore a rise in AMP, coupled with a fall in ATP, that are the key signals activating
AMPK, although increases in ADP may play a secondary rôle.
Thus, AMPK is switched on by cellular energy stress, signified here by red turning to green.
An obvious analogy is that the AMPK system is the cellular equivalent of the system
in your mobile phone (or cell phone) that monitors the state of the battery charge.
However, it's much more than that, because it doesn't just monitor a falling energy state
in the cell, but it also does something about it.
In short, what it does is to switch on catabolic pathways that generate more ATP,
while at the same time switching off energy-consuming processes
that are not essential to short-term survival of the cell.